Patents/Inventors

Ka-man Venus Lai

Seattle, WAUS14 patents

16 Patents

US124715792025
Mouse Model of DITRA Disease and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites
US124192822025
0 cites
US123695702025
Humanized IL-15 Animals
Regeneron Pharmaceuticals, Inc.
0 cites
US123428012025
Methods for Producing Antigen-binding Proteins Against Foreign Antigens
Regeneron Pharmaceuticals, Inc.
0 cites
US120895752024
Genetically Modified Mouse That Expresses Humanized PD1 and PD-L1 Proteins
Regeneron Pharmaceuticals, Inc.
0 cites
US120656612024
Genetic Modification of Rats
Regeneron Pharmaceuticals, Inc.
0 cites
US120375962024
Targeted Modification of Rat Genome
Regeneron Pharmaceuticals, Inc.
0 cites
US119375872024
0 cites
US119328592024
Nuclease-mediated DNA Assembly
Regeneron Pharmaceuticals, Inc.
0 cites
US118209972023
Methods and Compositions for the Targeted Modification of a Genome
Regeneron Pharmaceuticals, Inc.
0 cites
US117301502023
Fibrillin-1 Mutations for Modeling Neonatal Progeroid Syndrome with Congenital Lipodystrophy
Regeneron Pharmaceuticals, Inc.
0 cites
US116978282023
Methods and Compositions for Targeted Genetic Modification Using Paired Guide Rnas
Regeneran Pharmaceuticals, Inc.
0 cites
US116840502023
Non-human Animals Having a Humanized Programmed Cell Death 1 Gene
Regeneran Pharmaceuticals, Inc.
0 cites
US115895622023
Mouse Model of DITRA Disease and Uses Thereof
Regeneran Pharmaceuticals, Inc.
0 cites
US115471002023
Method for Screening Gene Expression in Lincrna-deficient Mice or Rats
Regeneron Pharmaceuticals, Inc.
0 cites
US115471012023
Non-human Animals Having a Disruption in a C9ORF72 Locus
Regeneron Pharmaceuticals, Inc.
0 cites